Fennec Pharmaceuticals Inc.
PO Box 13628, 68 TW Alexander Drive
Research Triangle Park, NC 27709
December 8, 2022
Via EDGAR Correspondence
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington D. C. 20549
|Re:||Acceleration of Effective Date|
|Fennec Pharmaceuticals Inc.|
|Registration Statement on Form S-3|
|File No. 333-268632|
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 p.m., Eastern Time, on December 12, 2022, or as soon thereafter as is practicable.
|Very truly yours,|
|FENNEC PHARMACEUTICALS INC.|
|By:||/s/ Rostislav Raykov|
|Chief Executive Officer|